Leadership Team:

Rachel Whyte, Patient Partner
Brent Edwards, University of Calgary
Elizabeth Zimmerman, McGill University

Platform aims:

• This platform will focus on the mechanisms of bone metabolism, its impact on bone mass and quality, and how it is influenced by lifestyle factors, genetics and disease.
• We will include bone, muscle, fat, joint, and neural interactions related to musculoskeletal health for common bone disorders and rare bone diseases spanning childhood to older age.
• There is an emphasis on the identification of new pharmacological targets and novel use of drugs already available.
• Methodologies such as imaging, biomechanics, and advanced analytics including machine learning are important and link to clinical research.